SOPHiA GENETICS SA Deferred Tax Expense Income
SOPHiA GENETICS SA (SOPH) reported Deferred Tax Expense Income of -$30.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2026-03-03
| Period end | Deferred Tax Expense Income 12 month |
|---|---|
| 2025-12-31 | -$30.00K 20-F · filed 2026-03-03 |
| 2024-12-31 | -$47.00K 20-F · filed 2026-03-03 |
| 2023-12-31 | $231.00K 20-F · filed 2026-03-03 |
| 2022-12-31 | -$118.00K 20-F · filed 2025-03-04 |
| 2021-12-31 | $58.00K 20-F · filed 2024-03-05 |
| 2020-12-31 | -$1.96M 20-F · filed 2023-03-07 |